FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283708332> ?p ?o ?g. }

• W4283708332 endingPage "23" @default.
• W4283708332 startingPage "17" @default.
• W4283708332 abstract "National heart failure (HF) guidelines recommend that in patients with HF with preserved ejection fraction (EF;HFpEF) and hypertension, systolic blood pressure (SBP) should be maintained below 130 mmHg. The objective of the study is to examine the association between initiation of anti-hypertensive drugs and outcomes in patients with HFpEF with persistent hypertension.Of the 8873 hospitalized patients with HFpEF (EF ≥50%) with a history of hypertension without renal failure in Medicare-linked OPTIMIZE-HF, 3315 had a discharge SBP ≥130 mmHg, of whom 1971 were not receiving anti-hypertensive drugs, thiazides and calcium channel blockers, before hospitalization. Of these, 366 received discharge prescriptions for those drugs. We assembled a propensity score-matched cohort of 365 pairs of patients initiated and not initiated on anti-hypertensive drugs, balanced on 37 baseline characteristics. Hazard ratios (HR) and 95% confidence intervals (CI) for outcomes associated with anti-hypertensive drug initiation were estimated in the matched cohort.Matched patients (n = 730) had a mean age of 78 years; 67% were women and 17% African Americans. During 6 (median 2.5) years of follow-up, 66% of the patients died and 45% had HF readmission. HRs (95% CIs) for all-cause mortality at 30 days, 12 months and 6 years associated with anti-hypertensive drug initiation were 0.64 (0.30-1.36), 0.70 (0.51-0.97), and 0.95 (0.79-1.13), respectively. Respective HRs (95% CIs) for HF readmission were 1.65 (0.97-2.80), 1.18 (0.90-1.56) and 1.09 (0.88-1.35).Among hospitalized older patients with HFpEF with uncontrolled hypertension, the initiation of therapy with anti-hypertensive drugs was not associated with all-cause mortality or hospital readmission." @default.
• W4283708332 created "2022-06-30" @default.
• W4283708332 creator A5005041969 @default.
• W4283708332 creator A5005408656 @default.
• W4283708332 creator A5016865558 @default.
• W4283708332 creator A5023202213 @default.
• W4283708332 creator A5030873899 @default.
• W4283708332 creator A5034132215 @default.
• W4283708332 creator A5036581291 @default.
• W4283708332 creator A5053175918 @default.
• W4283708332 creator A5070928171 @default.
• W4283708332 creator A5078294568 @default.
• W4283708332 creator A5082235948 @default.
• W4283708332 creator A5083912693 @default.
• W4283708332 creator A5091070572 @default.
• W4283708332 date "2022-07-01" @default.
• W4283708332 modified "2023-10-11" @default.
• W4283708332 title "Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension" @default.
• W4283708332 cites W2042714602 @default.
• W4283708332 cites W2064307714 @default.
• W4283708332 cites W2092271757 @default.
• W4283708332 cites W2119340816 @default.
• W4283708332 cites W2125241858 @default.
• W4283708332 cites W2150291618 @default.
• W4283708332 cites W2156371934 @default.
• W4283708332 cites W2164673596 @default.
• W4283708332 cites W2170683849 @default.
• W4283708332 cites W2545458768 @default.
• W4283708332 cites W2550696258 @default.
• W4283708332 cites W2597503617 @default.
• W4283708332 cites W2604834379 @default.
• W4283708332 cites W2609605008 @default.
• W4283708332 cites W2769520135 @default.
• W4283708332 cites W2788284833 @default.
• W4283708332 cites W2949566731 @default.
• W4283708332 cites W2950602628 @default.
• W4283708332 cites W2963747861 @default.
• W4283708332 cites W3012482957 @default.
• W4283708332 cites W3014404577 @default.
• W4283708332 cites W3037791565 @default.
• W4283708332 cites W3047531789 @default.
• W4283708332 cites W3091453311 @default.
• W4283708332 cites W3117718868 @default.
• W4283708332 cites W3162256210 @default.
• W4283708332 cites W3217086902 @default.
• W4283708332 cites W4296216349 @default.
• W4283708332 doi "https://doi.org/10.1016/j.pcad.2022.06.009" @default.
• W4283708332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35777433" @default.
• W4283708332 hasPublicationYear "2022" @default.
• W4283708332 type Work @default.
• W4283708332 citedByCount "0" @default.
• W4283708332 crossrefType "journal-article" @default.
• W4283708332 hasAuthorship W4283708332A5005041969 @default.
• W4283708332 hasAuthorship W4283708332A5005408656 @default.
• W4283708332 hasAuthorship W4283708332A5016865558 @default.
• W4283708332 hasAuthorship W4283708332A5023202213 @default.
• W4283708332 hasAuthorship W4283708332A5030873899 @default.
• W4283708332 hasAuthorship W4283708332A5034132215 @default.
• W4283708332 hasAuthorship W4283708332A5036581291 @default.
• W4283708332 hasAuthorship W4283708332A5053175918 @default.
• W4283708332 hasAuthorship W4283708332A5070928171 @default.
• W4283708332 hasAuthorship W4283708332A5078294568 @default.
• W4283708332 hasAuthorship W4283708332A5082235948 @default.
• W4283708332 hasAuthorship W4283708332A5083912693 @default.
• W4283708332 hasAuthorship W4283708332A5091070572 @default.
• W4283708332 hasBestOaLocation W42837083321 @default.
• W4283708332 hasConcept C126322002 @default.
• W4283708332 hasConcept C164705383 @default.
• W4283708332 hasConcept C207103383 @default.
• W4283708332 hasConcept C2777099384 @default.
• W4283708332 hasConcept C2778198053 @default.
• W4283708332 hasConcept C44249647 @default.
• W4283708332 hasConcept C71924100 @default.
• W4283708332 hasConcept C72563966 @default.
• W4283708332 hasConcept C78085059 @default.
• W4283708332 hasConcept C84393581 @default.
• W4283708332 hasConceptScore W4283708332C126322002 @default.
• W4283708332 hasConceptScore W4283708332C164705383 @default.
• W4283708332 hasConceptScore W4283708332C207103383 @default.
• W4283708332 hasConceptScore W4283708332C2777099384 @default.
• W4283708332 hasConceptScore W4283708332C2778198053 @default.
• W4283708332 hasConceptScore W4283708332C44249647 @default.
• W4283708332 hasConceptScore W4283708332C71924100 @default.
• W4283708332 hasConceptScore W4283708332C72563966 @default.
• W4283708332 hasConceptScore W4283708332C78085059 @default.
• W4283708332 hasConceptScore W4283708332C84393581 @default.
• W4283708332 hasLocation W42837083321 @default.
• W4283708332 hasLocation W42837083322 @default.
• W4283708332 hasOpenAccess W4283708332 @default.
• W4283708332 hasPrimaryLocation W42837083321 @default.
• W4283708332 hasRelatedWork W2027691053 @default.
• W4283708332 hasRelatedWork W2061321770 @default.
• W4283708332 hasRelatedWork W2098118216 @default.
• W4283708332 hasRelatedWork W2327585969 @default.
• W4283708332 hasRelatedWork W2779222010 @default.
• W4283708332 hasRelatedWork W2965474825 @default.
• W4283708332 hasRelatedWork W3033076790 @default.
• W4283708332 hasRelatedWork W3095613549 @default.

• next